Heron Therapeutics, Inc. (HRTX)

NASDAQ: HRTX · IEX Real-Time Price · USD

2.590

-0.050 (-1.89%)

At close: Apr 22, 2024, 4:00 PM

2.710

+0.120 (4.63%)

Pre-market: Apr 23, 2024, 8:39 AM EDT

Heron Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Cash & Equivalents	28.68	15.36	90.54	105.14	71.9	31.84	144.58	13.41	75.18	72.68	Upgrade
Short-Term Investments	51.73	69.49	67.04	103.35	319.07	300.54	27.8	37.72	55.99	0	Upgrade
Cash & Cash Equivalents	80.41	84.85	157.58	208.49	390.97	332.37	172.38	51.14	131.17	72.68	Upgrade
Cash Growth	-5.24%	-46.15%	-24.42%	-46.67%	17.63%	92.81%	237.09%	-61.01%	80.48%	0.54%	Upgrade
Receivables	60.14	52.05	35.5	41.85	39.88	64.65	41.87	1.96	0	0	Upgrade
Inventory	42.11	54.57	48.38	41.91	24.97	39.03	10.11	5.34	0	0	Upgrade
Other Current Assets	6.12	13.96	12.96	21.95	23.25	11.19	3.7	3.71	3.59	1.06	Upgrade
Total Current Assets	188.77	205.44	254.42	314.2	479.06	447.25	228.06	62.14	134.75	73.73	Upgrade
Property, Plant & Equipment	25.6	29.81	33.56	39.01	33.37	14.68	5.98	5.08	3.05	2.82	Upgrade
Other Long-Term Assets	8.13	15.71	17.72	0.35	0.35	0.25	0.26	0.26	0.05	0.13	Upgrade
Total Long-Term Assets	33.73	45.52	51.28	39.36	33.72	14.93	6.24	5.34	3.09	2.95	Upgrade
Total Assets	222.51	250.95	305.71	353.56	512.78	462.18	234.31	67.48	137.85	76.68	Upgrade
Accounts Payable	3.24	3.23	3.8	0.53	2.76	16.86	18.77	6.81	3.3	2.55	Upgrade
Deferred Revenue	0	0	0	0	0	0	2.76	1.1	0	0	Upgrade
Current Debt	3.08	2.69	2.42	10.05	7.55	4.57	28.68	2.91	2.22	1.6	Upgrade
Other Current Liabilities	73.37	76.44	64.84	91.93	86.4	70.58	52.96	27.91	14.21	9.47	Upgrade
Total Current Liabilities	79.69	82.36	71.06	102.5	96.71	92.02	103.17	38.73	19.74	13.62	Upgrade
Long-Term Debt	176.55	154.78	157.08	14.56	12.24	0	0	50	0	0	Upgrade
Other Long-Term Liabilities	0.24	0.24	0	0	0	0	0	0	0	0	Upgrade
Total Long-Term Liabilities	176.79	155.02	157.08	14.56	12.24	0	0	50	0	0	Upgrade
Total Liabilities	256.48	237.38	228.14	117.06	108.95	92.02	103.17	88.73	19.74	13.62	Upgrade
Total Debt	179.63	157.48	159.5	24.61	19.79	4.57	28.68	52.91	2.22	1.6	Upgrade
Debt Growth	14.07%	-1.27%	548.06%	24.35%	332.71%	-84.05%	-45.79%	2281.23%	39.05%	55.90%	Upgrade
Retained Earnings	-1,906.01	-1,795.46	-1,613.43	-1,392.75	-1,165.47	-960.72	-783.46	-585.97	-412.83	-315.24	Upgrade
Comprehensive Income	0.01	-0.02	-0.01	0.26	0.09	-0.09	-0.01	-0.02	-0.04	0	Upgrade
Shareholders' Equity	-33.97	13.57	77.57	236.49	403.84	370.16	131.14	-21.25	118.11	63.06	Upgrade
Net Cash / Debt	-99.22	-72.63	-1.92	183.88	371.18	327.8	143.7	-1.77	128.94	71.08	Upgrade
Net Cash / Debt Growth	-	-	-	-50.46%	13.23%	128.12%	-	-	81.41%	-0.26%	Upgrade
Net Cash Per Share	-0.72	-0.67	-0.02	2.03	4.54	4.48	2.66	-0.05	3.90	2.68	Upgrade
Working Capital	109.09	123.08	183.37	211.69	382.36	355.23	124.89	23.41	115.02	60.11	Upgrade
Book Value Per Share	-0.25	0.13	0.79	2.60	4.94	5.06	2.43	-0.56	3.57	2.37	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).